[固体がんに関連した拡散性血管内凝固]

Yoshinobu Seki^1,2

¹Department of Hematology, Niigata University Medical and Dental Hospital.

[Rinsho ketsueki] The Japanese journal of clinical hematology

|September 3, 2025

まとめ

分散性血管内凝固 (DIC) は癌の合併症である. DICの早期診断と治療は,予後と生活の質の改善に不可欠です.

科学分野:

腫瘍学
血液学
トロンボシス

背景:

散布性血管内凝固 (DIC) は,固体がんに関連するパラネオプラスティック症候群である.
DICは,がん患者の場合,慢性または急性,重症な状態として現れます.
癌に関連した結血症 (CAT) は高血栓状態であり,DVT,PE,脳梗塞などの結血症を引き起こします.

研究の目的:

固体がんにおけるDICの病原性,診断,治療をレビューする.
DIC管理のための2024年日本臨床実践ガイドラインに基づいてガイドラインを提供すること.

主な方法:

固体がんにおけるDICに焦点を当てた文献レビュー.
日本血栓症および血静学会による2024年臨床実務ガイドラインの分析

主要な成果:

慢性的なDIC,バランスの取れた血小板減少および血小板の産生を伴う固体癌は一般的です.
迅速に発症し,重度のDICは,特定の拡散した癌で発生する可能性があります.
DICの早期診断と治療は患者の健康に不可欠です

結論:

DICは,固体がんの管理において重要な懸念事項である.
DICの病原性を理解し,臨床ガイドラインを遵守することが不可欠です.
DICの効果的な管理は,がん患者の予後と生活の質を改善することができます.

キーワード:

分散型血管内凝固 JSTH臨床実務ガイドライン2024 生活の質固体がん

さらに関連する動画

09:42

Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis

Published on: June 26, 2019

8.9K

07:26

Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research

Published on: September 15, 2023

1.8K

関連する概念動画

01:24

Disorders of Hemostasis

1.2K

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

1.2K

02:30

Metastasis

5.7K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

5.7K

01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

889

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

889

01:35

Cancer Cell Migration through Invadopodia

2.4K

Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...